Ann: AnteoTech COVID-19 Antigen Test Progress Update, page-478

My first post in 3-4 years as a long term (11 years) and large holder. I can only ask that we remain patient and trust the best management team the company has had in my history of holding.
The lessons learned are very important but not as critical as
where we are now.
I would like to discuss manufacturing of a Covid test. Maybe it is assumed but here is what I believe is required.
Axxin produce a Reader which can do multiple tests.
Axxin also has production of empty cartridges for
their reader.
Anteo needs to fill liquid into the cartridge and design the liquid path.
What does this mean ?
Anteo can produce litres of product and a manufacturer needs to insert consistently into a cartridge.
Axxin need to make the device with any modifications.
This does not seem a huge manufacturing hurdle.
Axxin has the ability to produce devices at scale,
however we do not need 1 device per test.
If we assume 1 device per 50 tests then all we need to
do is ensure we produce cartridges at scale given Axxin can produce the reader.
I believe the manufacturing hurdle is not as significant and suits Anteo to produce consistent litres that can be provided to a cartridge manufacturer.
Welcome a discussion on this topic as maybe manufacturing barrier is not a huge hurdle and timelines for revenue are achievable.